Magdalena Gorska
Concepts (352)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Estradiol | 6 | 2016 | 452 | 2.480 |
Why?
| Asthma | 21 | 2022 | 2066 | 2.330 |
Why?
| Osteosarcoma | 5 | 2016 | 66 | 2.040 |
Why?
| Vehicle Emissions | 3 | 2020 | 48 | 1.730 |
Why?
| Adaptor Proteins, Signal Transducing | 8 | 2012 | 374 | 1.520 |
Why?
| Th2 Cells | 8 | 2020 | 157 | 1.510 |
Why?
| Nitric Oxide Synthase Type I | 3 | 2015 | 26 | 1.500 |
Why?
| Killer Cells, Natural | 4 | 2020 | 383 | 1.460 |
Why?
| Maternal Exposure | 4 | 2020 | 138 | 1.410 |
Why?
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 4 | 2021 | 21 | 1.050 |
Why?
| Bone Neoplasms | 3 | 2016 | 194 | 0.950 |
Why?
| Interleukin-17 | 4 | 2020 | 106 | 0.880 |
Why?
| Lactams, Macrocyclic | 2 | 2013 | 46 | 0.840 |
Why?
| Benzoquinones | 2 | 2013 | 44 | 0.840 |
Why?
| Prenatal Exposure Delayed Effects | 2 | 2020 | 447 | 0.800 |
Why?
| Antineoplastic Agents | 4 | 2016 | 1893 | 0.760 |
Why?
| Granzymes | 1 | 2020 | 40 | 0.720 |
Why?
| Mutation, Missense | 2 | 2012 | 296 | 0.710 |
Why?
| Oxidative Stress | 6 | 2016 | 1093 | 0.690 |
Why?
| Lymphocytes | 5 | 2021 | 344 | 0.650 |
Why?
| Protein Tyrosine Phosphatases | 5 | 2016 | 147 | 0.600 |
Why?
| Chaperonin 60 | 2 | 2016 | 12 | 0.590 |
Why?
| Bronchial Hyperreactivity | 5 | 2015 | 96 | 0.590 |
Why?
| Mice | 23 | 2022 | 15052 | 0.580 |
Why?
| Heat-Shock Proteins | 2 | 2016 | 113 | 0.570 |
Why?
| Signal Transduction | 13 | 2021 | 4541 | 0.570 |
Why?
| Antibiotics, Antineoplastic | 2 | 2016 | 114 | 0.560 |
Why?
| Estrogen Antagonists | 1 | 2016 | 39 | 0.540 |
Why?
| Estrogen Receptor beta | 1 | 2016 | 35 | 0.530 |
Why?
| Apoptosis | 6 | 2016 | 2377 | 0.530 |
Why?
| DNA Breaks | 1 | 2015 | 3 | 0.520 |
Why?
| Mitochondrial Proteins | 2 | 2016 | 219 | 0.510 |
Why?
| Allergens | 6 | 2022 | 418 | 0.510 |
Why?
| Bacterial Outer Membrane Proteins | 4 | 2016 | 58 | 0.510 |
Why?
| Intracellular Signaling Peptides and Proteins | 6 | 2021 | 388 | 0.500 |
Why?
| Interleukin-1beta | 1 | 2017 | 370 | 0.500 |
Why?
| Antineoplastic Agents, Hormonal | 1 | 2016 | 139 | 0.500 |
Why?
| Cell Line, Tumor | 8 | 2016 | 2751 | 0.500 |
Why?
| Neuroblastoma | 1 | 2016 | 130 | 0.500 |
Why?
| Protein Processing, Post-Translational | 5 | 2016 | 401 | 0.480 |
Why?
| Virus Diseases | 1 | 2017 | 200 | 0.480 |
Why?
| Receptors, Antigen, T-Cell | 2 | 2011 | 630 | 0.480 |
Why?
| Neurodegenerative Diseases | 1 | 2016 | 92 | 0.470 |
Why?
| Animals | 28 | 2022 | 32102 | 0.470 |
Why?
| Hippocampus | 2 | 2015 | 709 | 0.460 |
Why?
| Leukocyte Common Antigens | 4 | 2015 | 76 | 0.460 |
Why?
| CD4-Positive T-Lymphocytes | 4 | 2021 | 965 | 0.440 |
Why?
| Cell Survival | 8 | 2016 | 1024 | 0.440 |
Why?
| Neoplasm Proteins | 1 | 2016 | 385 | 0.430 |
Why?
| Lymphopenia | 1 | 2012 | 50 | 0.420 |
Why?
| Inflammation | 2 | 2017 | 2499 | 0.410 |
Why?
| Disease Models, Animal | 8 | 2022 | 3580 | 0.410 |
Why?
| Neoplasms | 2 | 2016 | 2118 | 0.400 |
Why?
| HSP90 Heat-Shock Proteins | 1 | 2012 | 43 | 0.400 |
Why?
| T-Lymphocytopenia, Idiopathic CD4-Positive | 1 | 2011 | 7 | 0.400 |
Why?
| Cell Proliferation | 9 | 2021 | 2194 | 0.400 |
Why?
| Lymphocyte Activation | 6 | 2021 | 1057 | 0.390 |
Why?
| Air Pollutants | 1 | 2013 | 246 | 0.360 |
Why?
| Drug Screening Assays, Antitumor | 3 | 2016 | 180 | 0.350 |
Why?
| Interleukin-13 | 3 | 2020 | 126 | 0.350 |
Why?
| Cell Differentiation | 4 | 2020 | 1700 | 0.340 |
Why?
| rab GTP-Binding Proteins | 2 | 2010 | 63 | 0.340 |
Why?
| Immunological Synapses | 1 | 2009 | 18 | 0.340 |
Why?
| Humans | 45 | 2021 | 115586 | 0.330 |
Why?
| Ovalbumin | 3 | 2022 | 166 | 0.330 |
Why?
| Hydrogen Peroxide | 4 | 2015 | 287 | 0.330 |
Why?
| Cytokines | 6 | 2020 | 1853 | 0.310 |
Why?
| Mitogen-Activated Protein Kinase 3 | 5 | 2021 | 147 | 0.310 |
Why?
| Interleukin-5 | 2 | 2008 | 30 | 0.290 |
Why?
| Capillary Permeability | 1 | 2007 | 138 | 0.280 |
Why?
| Immunity, Innate | 4 | 2021 | 731 | 0.270 |
Why?
| Mice, Inbred BALB C | 5 | 2022 | 1168 | 0.270 |
Why?
| Dynamin II | 1 | 2006 | 6 | 0.270 |
Why?
| Aurintricarboxylic Acid | 2 | 2016 | 4 | 0.270 |
Why?
| Bronchoalveolar Lavage | 2 | 2018 | 89 | 0.270 |
Why?
| Mice, Knockout | 6 | 2021 | 2604 | 0.270 |
Why?
| Respiratory Tract Diseases | 1 | 2007 | 142 | 0.260 |
Why?
| Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 2 | 2015 | 9 | 0.260 |
Why?
| T-Lymphocytes | 4 | 2009 | 1756 | 0.260 |
Why?
| Immunoglobulin E | 3 | 2018 | 328 | 0.260 |
Why?
| Th17 Cells | 2 | 2016 | 59 | 0.250 |
Why?
| Dose-Response Relationship, Drug | 4 | 2016 | 1870 | 0.240 |
Why?
| Mice, Inbred C57BL | 7 | 2021 | 4773 | 0.240 |
Why?
| Transforming Growth Factor beta | 4 | 2012 | 446 | 0.240 |
Why?
| Cell Death | 2 | 2016 | 326 | 0.240 |
Why?
| Disease Susceptibility | 2 | 2017 | 316 | 0.230 |
Why?
| Gene Expression Regulation | 4 | 2015 | 2353 | 0.230 |
Why?
| Jurkat Cells | 5 | 2015 | 128 | 0.230 |
Why?
| Cells, Cultured | 7 | 2020 | 3914 | 0.230 |
Why?
| Bronchoalveolar Lavage Fluid | 3 | 2022 | 608 | 0.230 |
Why?
| NF-kappa B | 1 | 2007 | 639 | 0.220 |
Why?
| MAP Kinase Signaling System | 4 | 2021 | 275 | 0.220 |
Why?
| Catalytic Domain | 4 | 2016 | 202 | 0.210 |
Why?
| Pregnancy | 4 | 2020 | 5548 | 0.210 |
Why?
| Molecular Docking Simulation | 4 | 2016 | 102 | 0.200 |
Why?
| MAP Kinase Kinase 1 | 2 | 2012 | 66 | 0.190 |
Why?
| Immune System | 1 | 2003 | 173 | 0.190 |
Why?
| Pleurotus | 1 | 2021 | 1 | 0.190 |
Why?
| src-Family Kinases | 4 | 2012 | 88 | 0.190 |
Why?
| Tumor Suppressor Protein p53 | 2 | 2016 | 449 | 0.190 |
Why?
| Phosphorylation | 5 | 2021 | 1571 | 0.180 |
Why?
| Nitric Oxide | 2 | 2016 | 832 | 0.180 |
Why?
| Membrane Proteins | 2 | 2021 | 1024 | 0.180 |
Why?
| Interleukin-33 | 2 | 2017 | 39 | 0.180 |
Why?
| Protein Binding | 7 | 2016 | 1917 | 0.180 |
Why?
| Interleukin-7 Receptor alpha Subunit | 1 | 2020 | 11 | 0.180 |
Why?
| Receptors, Prostaglandin | 1 | 2020 | 22 | 0.180 |
Why?
| Protein Transport | 2 | 2013 | 400 | 0.170 |
Why?
| Hypersensitivity | 1 | 2003 | 260 | 0.170 |
Why?
| Carrier Proteins | 1 | 2004 | 701 | 0.170 |
Why?
| Enzyme Activation | 6 | 2012 | 793 | 0.170 |
Why?
| Female | 16 | 2021 | 59913 | 0.170 |
Why?
| Immunologic Memory | 1 | 2021 | 314 | 0.160 |
Why?
| Mitogen-Activated Protein Kinase 1 | 3 | 2010 | 165 | 0.160 |
Why?
| G2 Phase Cell Cycle Checkpoints | 2 | 2016 | 41 | 0.160 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 2 | 2016 | 44 | 0.160 |
Why?
| Colonic Neoplasms | 1 | 2021 | 222 | 0.160 |
Why?
| Receptors, Immunologic | 1 | 2020 | 203 | 0.160 |
Why?
| Interleukin-9 | 1 | 2017 | 10 | 0.150 |
Why?
| Interleukin-1 Receptor-Like 1 Protein | 1 | 2017 | 22 | 0.150 |
Why?
| Adoptive Transfer | 3 | 2021 | 199 | 0.150 |
Why?
| Virulence Factors | 2 | 2016 | 139 | 0.150 |
Why?
| Enzyme Inhibitors | 3 | 2015 | 757 | 0.140 |
Why?
| Immunization | 2 | 2018 | 401 | 0.140 |
Why?
| Epigenesis, Genetic | 1 | 2021 | 526 | 0.140 |
Why?
| Endocytosis | 2 | 2009 | 152 | 0.140 |
Why?
| Lymphocyte Subsets | 1 | 2017 | 79 | 0.140 |
Why?
| Carcinoma, Mucoepidermoid | 1 | 2016 | 15 | 0.140 |
Why?
| Yersinia | 1 | 2016 | 2 | 0.140 |
Why?
| Toluidines | 1 | 2016 | 6 | 0.140 |
Why?
| Rosaniline Dyes | 1 | 2016 | 10 | 0.140 |
Why?
| Acetylation | 2 | 2016 | 212 | 0.140 |
Why?
| Enzyme Induction | 2 | 2014 | 85 | 0.140 |
Why?
| Benzenesulfonates | 1 | 2016 | 21 | 0.140 |
Why?
| Drug Resistance | 1 | 2017 | 162 | 0.140 |
Why?
| Caffeic Acids | 1 | 2016 | 2 | 0.130 |
Why?
| Yersinia enterocolitica | 1 | 2016 | 6 | 0.130 |
Why?
| Membrane Potential, Mitochondrial | 1 | 2016 | 55 | 0.130 |
Why?
| Succinates | 1 | 2016 | 18 | 0.130 |
Why?
| Cell Cycle Checkpoints | 1 | 2016 | 84 | 0.130 |
Why?
| Cell Culture Techniques | 2 | 2016 | 344 | 0.130 |
Why?
| Microtubule Proteins | 2 | 2007 | 15 | 0.130 |
Why?
| Tubulin Modulators | 1 | 2015 | 9 | 0.130 |
Why?
| Ferrous Compounds | 1 | 2015 | 22 | 0.130 |
Why?
| Tumor Suppressor p53-Binding Protein 1 | 1 | 2015 | 12 | 0.130 |
Why?
| Peroxides | 1 | 2015 | 20 | 0.130 |
Why?
| Drug Synergism | 1 | 2016 | 317 | 0.130 |
Why?
| Reactive Nitrogen Species | 1 | 2015 | 24 | 0.130 |
Why?
| M Phase Cell Cycle Checkpoints | 1 | 2015 | 23 | 0.130 |
Why?
| Cell Line, Transformed | 1 | 2015 | 133 | 0.130 |
Why?
| Cellular Senescence | 1 | 2016 | 153 | 0.130 |
Why?
| Calcifediol | 1 | 2015 | 29 | 0.130 |
Why?
| Doxorubicin | 1 | 2016 | 290 | 0.130 |
Why?
| Active Transport, Cell Nucleus | 2 | 2012 | 111 | 0.130 |
Why?
| Estrogen Receptor alpha | 1 | 2016 | 120 | 0.120 |
Why?
| Antibodies, Blocking | 1 | 2015 | 32 | 0.120 |
Why?
| Lipid Peroxidation | 1 | 2015 | 138 | 0.120 |
Why?
| Mucus | 2 | 2017 | 55 | 0.120 |
Why?
| Transcription, Genetic | 2 | 2013 | 1310 | 0.120 |
Why?
| Cytokinesis | 1 | 2015 | 46 | 0.120 |
Why?
| Histones | 2 | 2016 | 540 | 0.120 |
Why?
| CD4 Lymphocyte Count | 2 | 2012 | 257 | 0.120 |
Why?
| Muscle Fibers, Skeletal | 1 | 2016 | 169 | 0.120 |
Why?
| Lung | 2 | 2022 | 3672 | 0.120 |
Why?
| p38 Mitogen-Activated Protein Kinases | 3 | 2016 | 263 | 0.120 |
Why?
| Immune Tolerance | 2 | 2009 | 332 | 0.120 |
Why?
| Vitamins | 1 | 2015 | 151 | 0.120 |
Why?
| Neoplasm Metastasis | 1 | 2016 | 526 | 0.120 |
Why?
| Growth Inhibitors | 2 | 2012 | 45 | 0.120 |
Why?
| Molecular Dynamics Simulation | 4 | 2016 | 209 | 0.110 |
Why?
| Interleukin-4 | 2 | 2014 | 209 | 0.110 |
Why?
| Receptors, Aryl Hydrocarbon | 1 | 2013 | 39 | 0.110 |
Why?
| Biomarkers | 3 | 2020 | 3466 | 0.110 |
Why?
| Swine | 1 | 2016 | 704 | 0.110 |
Why?
| Carcinogenesis | 1 | 2015 | 178 | 0.110 |
Why?
| Myristic Acids | 1 | 2012 | 8 | 0.110 |
Why?
| DNA Damage | 1 | 2015 | 357 | 0.110 |
Why?
| Pre-Eclampsia | 1 | 2015 | 165 | 0.110 |
Why?
| Myristic Acid | 1 | 2012 | 10 | 0.110 |
Why?
| Interleukins | 1 | 2015 | 238 | 0.110 |
Why?
| Nuclear Receptor Co-Repressor 2 | 1 | 2012 | 14 | 0.110 |
Why?
| Nuclear Receptor Co-Repressor 1 | 1 | 2012 | 16 | 0.110 |
Why?
| Retinal Dystrophies | 1 | 2012 | 3 | 0.110 |
Why?
| Severe Combined Immunodeficiency | 1 | 2012 | 19 | 0.110 |
Why?
| Novobiocin | 1 | 2012 | 5 | 0.100 |
Why?
| Proto-Oncogene Proteins c-raf | 1 | 2012 | 43 | 0.100 |
Why?
| Models, Biological | 2 | 2012 | 1646 | 0.100 |
Why?
| Macrolides | 1 | 2012 | 56 | 0.100 |
Why?
| Pyrrolidinones | 1 | 2011 | 25 | 0.100 |
Why?
| Tissue Engineering | 1 | 2016 | 366 | 0.100 |
Why?
| Endosomes | 2 | 2010 | 125 | 0.100 |
Why?
| Culture Media | 1 | 2011 | 156 | 0.100 |
Why?
| Cyclin-Dependent Kinases | 1 | 2012 | 110 | 0.100 |
Why?
| Triazoles | 1 | 2012 | 132 | 0.090 |
Why?
| Neutrophils | 1 | 2016 | 1172 | 0.090 |
Why?
| Age of Onset | 1 | 2012 | 450 | 0.090 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 1147 | 0.090 |
Why?
| Biosensing Techniques | 1 | 2011 | 102 | 0.090 |
Why?
| Eosinophils | 2 | 2012 | 282 | 0.090 |
Why?
| Actins | 2 | 2009 | 383 | 0.090 |
Why?
| Indoles | 1 | 2012 | 309 | 0.090 |
Why?
| Enzyme Stability | 1 | 2010 | 73 | 0.090 |
Why?
| Dynamins | 1 | 2009 | 29 | 0.090 |
Why?
| Gene Expression Profiling | 2 | 2013 | 1536 | 0.090 |
Why?
| Ambrosia | 1 | 2009 | 7 | 0.080 |
Why?
| Th1 Cells | 1 | 2010 | 125 | 0.080 |
Why?
| Aspergillus | 1 | 2009 | 17 | 0.080 |
Why?
| Pyroglyphidae | 1 | 2009 | 17 | 0.080 |
Why?
| Interleukin-2 | 1 | 2010 | 417 | 0.080 |
Why?
| Blotting, Western | 1 | 2011 | 1153 | 0.080 |
Why?
| Myosins | 1 | 2009 | 126 | 0.080 |
Why?
| Epithelial Cells | 2 | 2016 | 961 | 0.080 |
Why?
| RNA, Small Interfering | 2 | 2010 | 544 | 0.080 |
Why?
| Interleukin-10 | 1 | 2010 | 299 | 0.080 |
Why?
| Arthritis, Experimental | 1 | 2010 | 133 | 0.080 |
Why?
| Antigen Presentation | 1 | 2009 | 189 | 0.080 |
Why?
| eIF-2 Kinase | 1 | 2008 | 24 | 0.080 |
Why?
| Cytoskeleton | 1 | 2009 | 177 | 0.080 |
Why?
| Multiprotein Complexes | 1 | 2009 | 145 | 0.080 |
Why?
| Mitochondria | 1 | 2013 | 750 | 0.080 |
Why?
| Proto-Oncogene Proteins c-fyn | 1 | 2007 | 12 | 0.070 |
Why?
| HSP27 Heat-Shock Proteins | 1 | 2007 | 11 | 0.070 |
Why?
| Umbilical Veins | 1 | 2007 | 58 | 0.070 |
Why?
| Transfection | 2 | 2007 | 866 | 0.070 |
Why?
| Adult | 7 | 2021 | 30718 | 0.070 |
Why?
| GATA3 Transcription Factor | 2 | 2020 | 25 | 0.070 |
Why?
| Eye Proteins | 1 | 2007 | 73 | 0.070 |
Why?
| Chemotaxis, Leukocyte | 1 | 2007 | 130 | 0.070 |
Why?
| Inflammation Mediators | 1 | 2010 | 479 | 0.070 |
Why?
| Recombinant Proteins | 2 | 2015 | 1243 | 0.070 |
Why?
| Feedback | 1 | 2007 | 148 | 0.070 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 2008 | 277 | 0.070 |
Why?
| Neurons | 1 | 2014 | 1298 | 0.070 |
Why?
| Bronchi | 1 | 2008 | 250 | 0.070 |
Why?
| Rhinitis, Allergic, Perennial | 1 | 2006 | 24 | 0.070 |
Why?
| Phosphoproteins | 1 | 2008 | 304 | 0.070 |
Why?
| Respiratory Mucosa | 1 | 2008 | 258 | 0.070 |
Why?
| Cloning, Molecular | 2 | 2004 | 523 | 0.070 |
Why?
| Intercellular Adhesion Molecule-1 | 1 | 2006 | 155 | 0.060 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 2 | 2021 | 157 | 0.060 |
Why?
| Middle Aged | 7 | 2021 | 26999 | 0.060 |
Why?
| Tyrosine | 1 | 2006 | 219 | 0.060 |
Why?
| Down-Regulation | 2 | 2021 | 601 | 0.060 |
Why?
| Mice, Transgenic | 1 | 2010 | 1970 | 0.060 |
Why?
| Molecular Structure | 2 | 2016 | 447 | 0.060 |
Why?
| Flow Cytometry | 3 | 2014 | 1083 | 0.060 |
Why?
| Polymerase Chain Reaction | 1 | 2007 | 1000 | 0.060 |
Why?
| Rats | 2 | 2010 | 5034 | 0.060 |
Why?
| Cell Line | 3 | 2016 | 2651 | 0.060 |
Why?
| src Homology Domains | 1 | 2004 | 33 | 0.060 |
Why?
| Lung Neoplasms | 1 | 2016 | 2207 | 0.060 |
Why?
| Nerve Tissue Proteins | 2 | 2009 | 535 | 0.060 |
Why?
| Helminth Proteins | 1 | 2002 | 19 | 0.050 |
Why?
| Fibroblasts | 1 | 2007 | 839 | 0.050 |
Why?
| Antigen-Presenting Cells | 1 | 2003 | 153 | 0.050 |
Why?
| Kinetics | 2 | 2015 | 1569 | 0.050 |
Why?
| Mutation | 1 | 2012 | 3364 | 0.050 |
Why?
| Alternaria | 1 | 2021 | 8 | 0.050 |
Why?
| Severity of Illness Index | 3 | 2017 | 2578 | 0.050 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2006 | 1137 | 0.050 |
Why?
| Endothelium, Vascular | 1 | 2007 | 845 | 0.050 |
Why?
| Heat-Shock Response | 1 | 2021 | 46 | 0.050 |
Why?
| Phytotherapy | 1 | 2021 | 66 | 0.050 |
Why?
| Caenorhabditis elegans Proteins | 1 | 2002 | 180 | 0.050 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 2020 | 139 | 0.040 |
Why?
| NIH 3T3 Cells | 2 | 2009 | 137 | 0.040 |
Why?
| Young Adult | 2 | 2010 | 10470 | 0.040 |
Why?
| B-Lymphocytes | 1 | 2003 | 773 | 0.040 |
Why?
| Chemokines | 2 | 2009 | 214 | 0.040 |
Why?
| Respiratory Hypersensitivity | 1 | 2017 | 63 | 0.040 |
Why?
| RNA | 1 | 2003 | 819 | 0.040 |
Why?
| Dietary Supplements | 1 | 2021 | 458 | 0.040 |
Why?
| Aged | 3 | 2010 | 19251 | 0.040 |
Why?
| Chaperonins | 1 | 2016 | 4 | 0.040 |
Why?
| Serum Amyloid A Protein | 1 | 2016 | 29 | 0.040 |
Why?
| Child | 1 | 2016 | 18488 | 0.030 |
Why?
| Ubiquitination | 1 | 2016 | 86 | 0.030 |
Why?
| Complement C3a | 1 | 2016 | 33 | 0.030 |
Why?
| Steroids | 1 | 2017 | 147 | 0.030 |
Why?
| Chronic Disease | 2 | 2015 | 1598 | 0.030 |
Why?
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 107 | 0.030 |
Why?
| Immunophenotyping | 1 | 2017 | 277 | 0.030 |
Why?
| Chlorogenic Acid | 1 | 2016 | 3 | 0.030 |
Why?
| Proteolysis | 1 | 2016 | 145 | 0.030 |
Why?
| Leukocyte Count | 1 | 2016 | 294 | 0.030 |
Why?
| Breeding | 1 | 2016 | 55 | 0.030 |
Why?
| Peracetic Acid | 1 | 2015 | 4 | 0.030 |
Why?
| Cell Extracts | 1 | 2015 | 16 | 0.030 |
Why?
| Cholesterol Side-Chain Cleavage Enzyme | 1 | 2015 | 14 | 0.030 |
Why?
| Phenotype | 1 | 2003 | 2829 | 0.030 |
Why?
| Yersinia pestis | 1 | 2015 | 34 | 0.030 |
Why?
| Enzyme Assays | 1 | 2015 | 22 | 0.030 |
Why?
| Respiratory Function Tests | 1 | 2017 | 535 | 0.030 |
Why?
| Molecular Conformation | 1 | 2015 | 139 | 0.030 |
Why?
| Plague | 1 | 2015 | 42 | 0.030 |
Why?
| Arachidonic Acid | 1 | 2015 | 117 | 0.030 |
Why?
| Cysteine | 1 | 2016 | 173 | 0.030 |
Why?
| Airway Remodeling | 1 | 2015 | 60 | 0.030 |
Why?
| Feedback, Physiological | 1 | 2015 | 73 | 0.030 |
Why?
| Lymphocyte Depletion | 1 | 2015 | 116 | 0.030 |
Why?
| Virulence | 1 | 2015 | 231 | 0.030 |
Why?
| Adolescent | 2 | 2010 | 17889 | 0.030 |
Why?
| Drug Interactions | 1 | 2015 | 347 | 0.030 |
Why?
| Bone Marrow Transplantation | 1 | 2015 | 239 | 0.030 |
Why?
| Lipopolysaccharides | 1 | 2016 | 826 | 0.030 |
Why?
| Carboxylic Acids | 1 | 2012 | 26 | 0.030 |
Why?
| Protein Structure, Tertiary | 1 | 2015 | 804 | 0.030 |
Why?
| Binding Sites | 1 | 2016 | 1177 | 0.030 |
Why?
| Bronchoscopy | 1 | 2014 | 245 | 0.030 |
Why?
| Dexamethasone | 1 | 2014 | 316 | 0.030 |
Why?
| Oxidation-Reduction | 1 | 2015 | 924 | 0.030 |
Why?
| Gene Silencing | 1 | 2012 | 175 | 0.030 |
Why?
| Quantitative Structure-Activity Relationship | 1 | 2011 | 13 | 0.030 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 2012 | 181 | 0.030 |
Why?
| Stereoisomerism | 1 | 2011 | 91 | 0.020 |
Why?
| Male | 5 | 2021 | 55949 | 0.020 |
Why?
| Models, Molecular | 1 | 2016 | 1390 | 0.020 |
Why?
| Clonal Anergy | 1 | 2010 | 53 | 0.020 |
Why?
| Case-Control Studies | 1 | 2017 | 3022 | 0.020 |
Why?
| Glucocorticoids | 1 | 2014 | 552 | 0.020 |
Why?
| Microarray Analysis | 1 | 2010 | 119 | 0.020 |
Why?
| Fluorescent Antibody Technique | 1 | 2010 | 398 | 0.020 |
Why?
| Cell Separation | 1 | 2010 | 293 | 0.020 |
Why?
| Placenta | 1 | 2015 | 624 | 0.020 |
Why?
| GTP Phosphohydrolases | 1 | 2009 | 66 | 0.020 |
Why?
| Bacteria | 1 | 2015 | 729 | 0.020 |
Why?
| Promoter Regions, Genetic | 1 | 2012 | 1122 | 0.020 |
Why?
| Chemokine CCL11 | 1 | 2008 | 22 | 0.020 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 795 | 0.020 |
Why?
| Algorithms | 1 | 2015 | 1490 | 0.020 |
Why?
| Autocrine Communication | 1 | 2008 | 43 | 0.020 |
Why?
| Disease Progression | 1 | 2015 | 2418 | 0.020 |
Why?
| Antibody Specificity | 1 | 2008 | 176 | 0.020 |
Why?
| JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 146 | 0.020 |
Why?
| Bone Marrow Cells | 1 | 2008 | 268 | 0.020 |
Why?
| Methacholine Chloride | 1 | 2006 | 47 | 0.020 |
Why?
| Bronchial Provocation Tests | 1 | 2006 | 53 | 0.020 |
Why?
| Dendritic Cells | 1 | 2009 | 438 | 0.020 |
Why?
| Nasal Mucosa | 1 | 2006 | 94 | 0.020 |
Why?
| Gene Expression | 1 | 2010 | 1435 | 0.020 |
Why?
| Blood Vessels | 1 | 2006 | 181 | 0.020 |
Why?
| Up-Regulation | 1 | 2007 | 820 | 0.010 |
Why?
| Pulmonary Fibrosis | 1 | 2007 | 330 | 0.010 |
Why?
| Receptors, Interleukin-5 | 1 | 2002 | 5 | 0.010 |
Why?
| Receptors, Interleukin | 1 | 2002 | 39 | 0.010 |
Why?
| Protein Kinase Inhibitors | 1 | 2008 | 790 | 0.010 |
Why?
| DNA Primers | 1 | 2002 | 514 | 0.010 |
Why?
| Comorbidity | 1 | 2006 | 1473 | 0.010 |
Why?
| Prevalence | 1 | 2006 | 2264 | 0.010 |
Why?
| Base Sequence | 1 | 2002 | 2114 | 0.010 |
Why?
| Amino Acid Sequence | 1 | 2002 | 2000 | 0.010 |
Why?
| Molecular Sequence Data | 1 | 2002 | 2790 | 0.010 |
Why?
|
|
Gorska's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|